Ausgabe 7/2021
Inhalt (12 Artikel)
Melittin inhibits the expression of key genes involved in tumor microenvironment formation by suppressing HIF-1α signaling in breast cancer cells
Zabih Mir Hassani, Mohammad Nabiuni, Kazem Parivar, Somayeh Abdirad, Latifeh Karimzadeh
Systematic identification of the cancer pathways and molecules related with breast cancer immunogenicity
Xiaoli Wang, Silu Xu, Lingli Huang, Lei Wang, Nan Wu
Peripheral androgen blockade in men with castrate-sensitive biochemical recurrent prostate cancer
Diane K. Reyes, Kenneth J. Pienta
Identification of key genes in the tumor microenvironment of lung adenocarcinoma
Wenxing Long, Qing Li, Jianfang Zhang, Hui Xie
Biological activity and molecular docking studies of some new quinolines as potent anticancer agents
Tuğba Kul Köprülü, Salih Ökten, Vildan Enisoğlu Atalay, Şaban Tekin, Osman Çakmak
ceRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma
Li Chen, Weijie Zou, Lei Zhang, Huijuan Shi, Zhi Li, Caifang Ni
Triple-arm androgen blockade for advanced prostate cancer: a review
Milap H. Desai, Meghana Parsi, Rashmika R. Potdar
Cancer stem cell characteristics and their potential as therapeutic targets
Jacqueline R. Lim, Josette Mouawad, Olivia K. Gorton, William A. Bubb, Ann H. Kwan
Immunotherapy era in the treatment of small cell lung cancer
Murat Araz, Melek Karakurt Eryilmaz
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in regard to Triggiani et al.
Cem Onal, Ezgi Oymak, Ozan Cem Guler
How should we manage non-small-cell lung cancer “not-otherwise-specified”?
Young Hak Kim, Yoshihiro Nishimura, Yasuhiro Funada
Correction to: Diosmetin induces apoptosis in ovarian cancer cells by activating reactive oxygen species and inhibiting the Nrf2 pathway
Feijie Zhao, Xiaoling Hong, Danjie Li, Zhentong Wei, Xinxin Ci, Songling Zhang